These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10588977)

  • 21. A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers.
    Gabrio BJ; Stein SW; Velasquez DJ
    Int J Pharm; 1999 Sep; 186(1):3-12. PubMed ID: 10469919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Issues surrounding MDI formulation development with non-CFC propellants.
    Kontny MJ; Destefano G; Jager PD; McNamara DP; Turi JS; Van Campen L
    J Aerosol Med; 1991; 4(3):181-7. PubMed ID: 10147677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developing an in vitro understanding of patient experience with hydrofluoroalkane-metered dose inhalers.
    Doub WH; Shah V; Limb S; Guo C; Liu X; Ngo D
    J Pharm Sci; 2014 Nov; 103(11):3648-3656. PubMed ID: 25228114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The challenge of reformulation.
    Smith IJ
    J Aerosol Med; 1995; 8 Suppl 1():S19-27. PubMed ID: 10150491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salmeterol HFA is as effective as salmeterol CFC in children and adults with persistent asthma.
    Chopra N; Williams M; Rimmer M; Kahl L; Jenkins M;
    Respir Med; 2005 Apr; 99 Suppl A():S1-S10. PubMed ID: 15777603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhaled corticosteroid delivery systems: clinical role of a breath-actuated device.
    Donnell D
    Eur Rev Med Pharmacol Sci; 2001; 5(1):7-16. PubMed ID: 11860222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Awareness of the ozone layer and acceptance of a new CFC-free metered dose inhaler among asthmatic patients.
    Liam CK; Lim KH
    Int J Tuberc Lung Dis; 1998 Aug; 2(8):683-9. PubMed ID: 9712285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic exposure to fluticasone propionate administered via metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant.
    Mackie AE; McDowall JE; Ventresca P; Bye A; Falcoz C; Daley-Yates PT
    Clin Pharmacokinet; 2000; 39 Suppl 1():17-22. PubMed ID: 11140429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler.
    Williams RO; Repka M; Liu J
    Drug Dev Ind Pharm; 1998 Aug; 24(8):763-70. PubMed ID: 9876524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmaceutical transition to non-CFC pressurized metered dose inhalers.
    Cripps A; Riebe M; Schulze M; Woodhouse R
    Respir Med; 2000 Jun; 94 Suppl B():S3-9. PubMed ID: 10919679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and performance of a new hydrofluoroalkane (HFA 134a)-based metered dose inhaler (MDI) of salmeterol.
    Peyron ID; Britto IL; Benissan LB; Tardieu BZ
    Respir Med; 2005 Apr; 99 Suppl A():S20-30. PubMed ID: 15777605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes in metered dose inhaler propellants].
    Chinet T
    Rev Mal Respir; 2000 Feb; 17(1):15-20. PubMed ID: 10756552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stratospheric ozone, global warming, and the principle of unintended consequences--an ongoing science and policy success story.
    Andersen SO; Halberstadt ML; Borgford-Parnell N
    J Air Waste Manag Assoc; 2013 Jun; 63(6):607-47. PubMed ID: 23858990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical efficacy and safety of fluticasone propionate 250 microg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma. French study group.
    Tonnel AB; Bons J; Legendre M; Prud'Homme A; Bugnas B; Evano-Celli I; Stuart AM
    Respir Med; 2000 Jun; 94 Suppl B():S29-34. PubMed ID: 10919683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The chlorofluorocarbon to hydrofluoroalkane transition: the effect on pressurized metered dose inhaler suspension stability.
    Brindley A
    J Allergy Clin Immunol; 1999 Dec; 104(6):S221-6. PubMed ID: 10588978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients.
    Langley SJ; Sykes AP; Batty EP; Masterson CM; Woodcock A
    Ann Allergy Asthma Immunol; 2002 May; 88(5):488-93. PubMed ID: 12027070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The technical transition to CFC-free inhalers.
    Tansey I
    Br J Clin Pract Suppl; 1997 May; 89():22-7. PubMed ID: 9519509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propellant gases in metered dose inhalers: their impact on the global environment.
    Balmes JR
    Respir Care; 1991 Sep; 36(9):1037-44. PubMed ID: 10145537
    [No Abstract]   [Full Text] [Related]  

  • 39. [Problems raised by the reformulation of inhalations after the removing of propulsors "chlorofluorocarbons" (CFC)].
    Aiache JM
    Ann Pharm Fr; 1997; 55(2):62-8. PubMed ID: 9181702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From closing the atmospheric ozone hole to reducing climate change. Lessons learned.
    Ewart GW; Rom WN; Braman SS; Pinkerton KE
    Ann Am Thorac Soc; 2015 Feb; 12(2):247-51. PubMed ID: 25706493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.